Related Content
Search Google Scholar for:
|
PNAS 101 (28): 10398-10403
Copyright © 2004 by the National Academy of Sciences.
Engagement of B7 on effector T cells by regulatory T cells prevents autoimmune disease
Silke Paust,
Linrong Lu,
Nami McCarty, and
Harvey Cantor *
Department of Cancer Immunology and AIDS, DanaFarber Cancer Institute, Department of Pathology, Harvard Medical School, 44 Binney Street, SM 722, Boston, MA 02115
Contributed by Harvey Cantor, May 24, 2004
Abstract:
Although there is considerable evidence that a subpopulation of regulatory CD4+CD25+ T cells can suppress the response of autoreactive T cells, the underlying molecular mechanism is not understood. We find that transmission of a suppressive signal by CD4CD25+ regulatory cells requires engagement of the B7 molecule expressed on target T cells. The response of T cells from B7-deficient mice is resistant to suppression in vitro, and these cells provoke a lethal wasting disease in lymphopenic mice despite the presence of regulatory T cells. Susceptibility of B7-deficient cells to suppression is restored by lentiviral-based expression of full-length, but not truncated, B7 lacking a transmembrane/cytoplasmic domain. Because expression of these B7 truncation mutants restores CD28-dependent costimulatory activity, these findings that indicate B7-based transmission of suppressive activity suggest new approaches to modifying autoimmune responses.
Abbreviations: T-reg, CD4 +CD25 + regulatory T cell; FACS, fluorescence-activated cell sorter; CTLA-4, cytotoxic T lymphocyte-associated antigen 4; GPI, glycosylphosphatidylinositol; wt, wild type; PE, phycoerythrin; Th, T helper; RAG-2, recombination activation gene 2; BM, bone marrow.
* To whom correspondence should be addressed. E-mail: harvey_cantor{at}dfci.harvard.edu. © 2004 by The National Academy of Sciences of the USA
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
- Naturally occurring regulatory T cells: markers, mechanisms, and manipulation.
- K. G. Schmetterer, A. Neunkirchner, and W. F. Pickl (2012)
FASEB J
26, 2253-2276
| Abstract »
| Full Text »
| PDF »
- Enhancement of Suboptimal CD8 Cytotoxic T Cell Effector Function In Vivo Using Antigen-Specific CD80 Defective T Cells.
- I. Puliaeva, K. Soloviova, M. Puliaiev, T. Lang, R. Puliaev, and C. S. Via (2011)
J. Immunol.
186, 291-304
| Abstract »
| Full Text »
| PDF »
- B7-H1/CD80 interaction is required for the induction and maintenance of peripheral T-cell tolerance.
- J.-J. Park, R. Omiya, Y. Matsumura, Y. Sakoda, A. Kuramasu, M. M. Augustine, S. Yao, F. Tsushima, H. Narazaki, S. Anand, et al. (2010)
Blood
116, 1291-1298
| Abstract »
| Full Text »
| PDF »
- Generation and Accumulation of Immunosuppressive Adenosine by Human CD4+CD25highFOXP3+ Regulatory T Cells.
- M. Mandapathil, B. Hilldorfer, M. J. Szczepanski, M. Czystowska, M. Szajnik, J. Ren, S. Lang, E. K. Jackson, E. Gorelik, and T. L. Whiteside (2010)
J. Biol. Chem.
285, 7176-7186
| Abstract »
| Full Text »
| PDF »
- Superagonistic CD28 stimulation of allogeneic T cells protects from acute graft-versus-host disease.
- N. Beyersdorf, X. Ding, T. Hunig, and T. Kerkau (2009)
Blood
114, 4575-4582
| Abstract »
| Full Text »
| PDF »
- Regulatory T cells: how do they suppress immune responses?.
- S. Sakaguchi, K. Wing, Y. Onishi, P. Prieto-Martin, and T. Yamaguchi (2009)
Int. Immunol.
21, 1105-1111
| Abstract »
| Full Text »
| PDF »
- Disruption of TGF-{beta} Signaling Prevents the Generation of Tumor-Sensitized Regulatory T Cells and Facilitates Therapeutic Antitumor Immunity.
- U. Petrausch, S. M. Jensen, C. Twitty, C. H. Poehlein, D. P. Haley, E. B. Walker, and B. A. Fox (2009)
J. Immunol.
183, 3682-3689
| Abstract »
| Full Text »
| PDF »
- CTLA-4 on alloreactive CD4 T cells interacts with recipient CD80/86 to promote tolerance.
- J. Kurtz, F. Raval, C. Vallot, J. Der, and M. Sykes (2009)
Blood
113, 3475-3484
| Abstract »
| Full Text »
| PDF »
- NK-Dependent Increases in CCL22 Secretion Selectively Recruits Regulatory T Cells to the Tumor Microenvironment.
- A. W. Mailloux and M. R. I. Young (2009)
J. Immunol.
182, 2753-2765
| Abstract »
| Full Text »
| PDF »
- Analysis of Adhesion Molecules, Target Cells, and Role of IL-2 in Human FOXP3+ Regulatory T Cell Suppressor Function.
- D. Q. Tran, D. D. Glass, G. Uzel, D. A. Darnell, C. Spalding, S. M. Holland, and E. M. Shevach (2009)
J. Immunol.
182, 2929-2938
| Abstract »
| Full Text »
| PDF »
- CD4+ regulatory T cells require CTLA-4 for the maintenance of systemic tolerance.
- R. H. Friedline, D. S. Brown, H. Nguyen, H. Kornfeld, J. Lee, Y. Zhang, M. Appleby, S. D. Der, J. Kang, and C. A. Chambers (2009)
J. Exp. Med.
206, 421-434
| Abstract »
| Full Text »
| PDF »
- Intratumoral Immune Cell Infiltrates, FoxP3, and Indoleamine 2,3-Dioxygenase in Patients with Melanoma Undergoing CTLA4 Blockade.
- A. Ribas, B. Comin-Anduix, J. S. Economou, T. R. Donahue, P. de la Rocha, L. F. Morris, J. Jalil, V. B. Dissette, I. P. Shintaku, J. A. Glaspy, et al. (2009)
Clin. Cancer Res.
15, 390-399
| Abstract »
| Full Text »
| PDF »
- Induction of T Regulatory Cells Attenuates Idiopathic Nephrotic Syndrome.
- L. Le Berre, S. Bruneau, J. Naulet, K. Renaudin, F. Buzelin, C. Usal, H. Smit, T. Condamine, J.-P. Soulillou, and J. Dantal (2009)
J. Am. Soc. Nephrol.
20, 57-67
| Abstract »
| Full Text »
| PDF »
- Defects in CTLA-4 are associated with abnormal regulatory T cell function in rheumatoid arthritis.
- F. Flores-Borja, E. C. Jury, C. Mauri, and M. R. Ehrenstein (2008)
PNAS
105, 19396-19401
| Abstract »
| Full Text »
| PDF »
- T-Cell Costimulation and Coinhibition in Atherosclerosis.
- I. Gotsman, A. H. Sharpe, and A. H. Lichtman (2008)
Circ. Res.
103, 1220-1231
| Abstract »
| Full Text »
| PDF »
- Dicer-dependent microRNA pathway safeguards regulatory T cell function.
- A. Liston, L.-F. Lu, D. O'Carroll, A. Tarakhovsky, and A. Y. Rudensky (2008)
J. Exp. Med.
205, 1993-2004
| Abstract »
| Full Text »
| PDF »
- A Novel B7-2 (CD86) Splice Variant with a Putative Negative Regulatory Role.
- E. K. Kapsogeorgou, H. M. Moutsopoulos, and M. N. Manoussakis (2008)
J. Immunol.
180, 3815-3823
| Abstract »
| Full Text »
| PDF »
- Tpl2 and ERK transduce antiproliferative T cell receptor signals and inhibit transformation of chronically stimulated T cells.
- C. Tsatsanis, K. Vaporidi, V. Zacharioudaki, A. Androulidaki, Y. Sykulev, A. N. Margioris, and P. N. Tsichlis (2008)
PNAS
105, 2987-2992
| Abstract »
| Full Text »
| PDF »
- A New Role of CTLA-4 on B Cells in Thymus-Dependent Immune Responses In Vivo.
- D. Quandt, H. Hoff, M. Rudolph, S. Fillatreau, and M. C. Brunner-Weinzierl (2007)
J. Immunol.
179, 7316-7324
| Abstract »
| Full Text »
| PDF »
- Tremelimumab (CP-675,206), a Cytotoxic T Lymphocyte Associated Antigen 4 Blocking Monoclonal Antibody in Clinical Development for Patients with Cancer.
- A. Ribas, D. C. Hanson, D. A. Noe, R. Millham, D. J. Guyot, S. H. Bernstein, P. C. Canniff, A. Sharma, and J. Gomez-Navarro (2007)
Oncologist
12, 873-883
| Abstract »
| Full Text »
| PDF »
- Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression.
- S. Deaglio, K. M. Dwyer, W. Gao, D. Friedman, A. Usheva, A. Erat, J.-F. Chen, K. Enjyoji, J. Linden, M. Oukka, et al. (2007)
J. Exp. Med.
204, 1257-1265
| Abstract »
| Full Text »
| PDF »
- Germinal Center Helper T Cells Are Dual Functional Regulatory Cells with Suppressive Activity to Conventional CD4+ T Cells.
- E. Marinova, S. Han, and B. Zheng (2007)
J. Immunol.
178, 5010-5017
| Abstract »
| Full Text »
| PDF »
- B7-Deficient Autoreactive T Cells Are Highly Susceptible to Suppression by CD4+CD25+ Regulatory T Cells.
- K. F. May Jr., X. Chang, H. Zhang, K. D. Lute, P. Zhou, E. Kocak, P. Zheng, and Y. Liu (2007)
J. Immunol.
178, 1542-1552
| Abstract »
| Full Text »
| PDF »
- Regulatory T cell-mediated suppression: potential role of ICER.
- J. Bodor, Z. Fehervari, B. Diamond, and S. Sakaguchi (2007)
J. Leukoc. Biol.
81, 161-167
| Abstract »
| Full Text »
| PDF »
- Blockade of CTLA-4 on CD4+CD25+ Regulatory T Cells Abrogates Their Function In Vivo.
- S. Read, R. Greenwald, A. Izcue, N. Robinson, D. Mandelbrot, L. Francisco, A. H. Sharpe, and F. Powrie (2006)
J. Immunol.
177, 4376-4383
| Abstract »
| Full Text »
| PDF »
- Arming Tumor-Reactive T Cells with Costimulator B7-1 Enhances Therapeutic Efficacy of the T Cells..
- G. Zheng, S. Liu, P. Wang, Y. Xu, and A. Chen (2006)
Cancer Res.
66, 6793-6799
| Abstract »
| Full Text »
| PDF »
- Emerging possibilities in the development and function of regulatory T cells.
- K. Wing, Z. Fehervari, and S. Sakaguchi (2006)
Int. Immunol.
18, 991-1000
| Abstract »
| Full Text »
| PDF »
- Interleukin-2-Dependent Mechanisms of Tolerance and Immunity In Vivo.
- P. A. Antony, C. M. Paulos, M. Ahmadzadeh, A. Akpinarli, D. C. Palmer, N. Sato, A. Kaiser, C. Heinrichs, C. A. Klebanoff, Y. Tagaya, et al. (2006)
J. Immunol.
176, 5255-5266
| Abstract »
| Full Text »
| PDF »
- In vivo sites and cellular mechanisms of T reg cell-mediated suppression.
- A. Y. Rudensky and D. J. Campbell (2006)
J. Exp. Med.
203, 489-492
| Abstract »
| Full Text »
| PDF »
- TGF-beta Requires CTLA-4 Early after T Cell Activation to Induce FoxP3 and Generate Adaptive CD4+CD25+ Regulatory Cells.
- S. G. Zheng, J. H. Wang, W. Stohl, K. S. Kim, J. D. Gray, and D. A. Horwitz (2006)
J. Immunol.
176, 3321-3329
| Abstract »
| Full Text »
| PDF »
- CD4+CD25+ Regulatory T Cells Inhibit the Antigen-Dependent Expansion of Self-Reactive T Cells In Vivo.
- T. D. Zwar, S. Read, I. R. van Driel, and P. A. Gleeson (2006)
J. Immunol.
176, 1609-1617
| Abstract »
| Full Text »
| PDF »
- Immunity and Tolerance to Aspergillus Involve Functionally Distinct Regulatory T Cells and Tryptophan Catabolism.
- C. Montagnoli, F. Fallarino, R. Gaziano, S. Bozza, S. Bellocchio, T. Zelante, W. P. Kurup, L. Pitzurra, P. Puccetti, and L. Romani (2006)
J. Immunol.
176, 1712-1723
| Abstract »
| Full Text »
| PDF »
- Antitumor Activity in Melanoma and Anti-Self Responses in a Phase I Trial With the Anti-Cytotoxic T Lymphocyte-Associated Antigen 4 Monoclonal Antibody CP-675,206.
- A. Ribas, L. H. Camacho, G. Lopez-Berestein, D. Pavlov, C. A. Bulanhagui, R. Millham, B. Comin-Anduix, J. M. Reuben, E. Seja, C. A. Parker, et al. (2005)
J. Clin. Oncol.
23, 8968-8977
| Abstract »
| Full Text »
| PDF »
- Regulation of B7.1 Costimulatory Molecule Is Mediated by the IFN Regulatory Factor-7 through the Activation of JNK in Lipopolysaccharide-Stimulated Human Monocytic Cells.
- W. Lim, K. Gee, S. Mishra, and A. Kumar (2005)
J. Immunol.
175, 5690-5700
| Abstract »
| Full Text »
| PDF »
- Both Regulatory T Cells and Antitumor Effector T Cells Are Primed in the Same Draining Lymph Nodes during Tumor Progression.
- T. Hiura, H. Kagamu, S. Miura, A. Ishida, H. Tanaka, J. Tanaka, F. Gejyo, and H. Yoshizawa (2005)
J. Immunol.
175, 5058-5066
| Abstract »
| Full Text »
| PDF »
- Selective targeting of regulatory T cells with CD28 superagonists allows effective therapy of experimental autoimmune encephalomyelitis.
- N. Beyersdorf, S. Gaupp, K. Balbach, J. Schmidt, K. V. Toyka, C.-H. Lin, T. Hanke, T. Hunig, T. Kerkau, and R. Gold (2005)
J. Exp. Med.
202, 445-455
| Abstract »
| Full Text »
| PDF »
- BALB/c mice have more CD4+CD25+ T regulatory cells and show greater susceptibility to suppression of their CD4+CD25- responder T cells than C57BL/6 mice.
- X. Chen, J. J. Oppenheim, and O. M. Z. Howard (2005)
J. Leukoc. Biol.
78, 114-121
| Abstract »
| Full Text »
| PDF »
- CD4+CD25+ Regulatory T Cells Restrain Pathogenic Responses during Leishmania amazonensis Infection.
- J. Ji, J. Masterson, J. Sun, and L. Soong (2005)
J. Immunol.
174, 7147-7153
| Abstract »
| Full Text »
| PDF »
|
|